AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Medulloblastoma
Related studies linked through entity extraction aliases.
Targeting MYC in High-Risk Medulloblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Parental Distress and Treatment Adherence in Pediatric Recurrent Medulloblastoma
- Status
- WITHDRAWN
- Phase
- N/A
Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
- Status
- NOT_YET_RECRUITING
- Phase
- NA
B7-H3.CD28Z.CART in CNS Neoplasms
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Status
- RECRUITING
- Phase
- PHASE1
CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
- Status
- RECRUITING
- Phase
- N/A
Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models
- Status
- COMPLETED
- Phase
- N/A
Intraoperatively Observed Site of Origin and Growth Pattern of Medulloblastoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
- Status
- RECRUITING
- Phase
- N/A
Digoxin Medulloblastoma Study
- Status
- RECRUITING
- Phase
- PHASE2
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
In Vitro Models From Pediatric Brain Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A